Should Biotechnology Stock Harpoon Therapeutics Inc (HARP) Be in Your Portfolio Wednesday?

Wednesday, November 22, 2023 01:13 PM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Harpoon Therapeutics Inc (HARP) Be in Your Portfolio Wednesday?

Harpoon Therapeutics Inc (HARP) is around the top of the Biotechnology industry according to InvestorsObserver. HARP received an overall rating of 67, which means that it scores higher than 67 percent of all stocks. Harpoon Therapeutics Inc also achieved a score of 87 in the Biotechnology industry, putting it above 87 percent of Biotechnology stocks. Biotechnology is ranked 53 out of the 148 industries.

HARP has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on HARP!

See Full HARP Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Harpoon Therapeutics Inc Stock Today?

Harpoon Therapeutics Inc (HARP) stock has fallen -1.46% while the S&P 500 has risen 0.47% as of 1:12 PM on Wednesday, Nov 22. HARP is lower by -$0.19 from the previous closing price of $12.99 on volume of 306,211 shares. Over the past year the S&P 500 has risen 13.88% while HARP has risen 83.64%. HARP lost -$8.71 per share the over the last 12 months. Click Here to get the full Stock Report for Harpoon Therapeutics Inc stock.